Patients HCPs
This site is for US residents only.

For adults with moderate to severe hidradenitis suppurativa

hero image

COSENTYX® (secukinumab) is the first FDA-approved medicine of its kind† to treat adults with moderate to severe hidradenitis suppurativa (HS).

Hidradenitis suppurativa (HS) is a chronic, or long-lasting, inflammatory skin condition. It is thought that an overactive immune system may contribute to inflammation in different areas of the body that can lead to HS symptoms, like bumps and abscesses that can hurt. Living with HS can be a daily challenge.

†COSENTYX targets and blocks IL-17A, a molecule thought to play a role in the inflammation that may contribute to HS symptoms.

Learn More About HS

Real results. Real relief from HS symptoms.

COSENTYX was proven to help adults with moderate to severe HS find relief at 16 weeks:

50% REDUCTION   
At least a 50% reduction in the number of inflammatory bumps and abscesses

NO INCREASE   
No increase in the number of abscesses and/or draining tunnels

In 2 clinical trials, 41% and 43% of adults taking COSENTYX 300 mg every 4 weeks (after 5 initial weekly doses) achieved at least a 50% reduction in the number of inflammatory bumps and abscesses, with no increase in the number of abscesses and/or draining tunnels at 16 weeks vs 29% and 26% taking placebo.

See Results

Proven experience

Since 2015, over 3.7 million COSENTYX prescriptions have been filled‡ in the United States.§

COSENTYX has had a well-studied safety profile since its launch in 2015 and has been approved to treat numerous conditions:

  • 2015 — adults with moderate to severe plaque psoriasis 

  • 2016 — adults with active ankylosing spondylitis and active psoriatic arthritis

  • 2020 — adults with active non-radiographic axial spondyloarthritis

  • 2021 — children with plaque psoriasis (6 years and older), psoriatic arthritis (2 years and older), and enthesitis-related arthritis (4 years and older)

  • 2023 — adults with moderate to severe hidradenitis suppurativa

‡Across all indications combined (not including HS).     
§As of March 2023.

How is COSENTYX different?

COSENTYX is the first biologic treatment of its kind to treat HS by specifically targeting and blocking IL-17A, a molecule that is thought to play a role in causing inflammation that may contribute to HS symptoms.
 

See how COSENTYX takes on HS—from the inside out. Watch a video of how COSENTYX is thought to help adults with HS.

How COSENTYX Works

Download our patient brochure to learn more about treating moderate to severe HS in adults with COSENTYX.

Savings & Support

Enroll in our Co-Pay offer and pay as little as $0 through the COSENTYX® Connect Co-Pay Program, if privately insured and otherwise eligible.

COSENTYX Connect real support personal solutions.

COSENTYX® Connect is a free, personalized support program for people taking or considering COSENTYX. Our goal is to make the COSENTYX experience as easy, affordable, and convenient as possible for you. Sign up now and you'll have access to a full range of services, like a dedicated COSENTYX® Connect Team, co-pay offer,* if eligible, and injection resources.

Learn More About COSENTYX® Connect

*Limitations apply. Valid only for those with private insurance. Program provides up to $16,000 annually for the cost of COSENTYX and up to $150 per infusion (up to $1,950 annually) for the cost of administration. Co-pay support for infusion administration cost not available in Rhode Island or Massachusetts. Offer not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice. See complete Terms & Conditions for details.

FIND A DOCTOR

REAL PEOPLE TAKING COSENTYX® (secukinumab) ARE SEEING REAL RESULTS.

Could you be one of them? Find a dermatologist in your area who has experience treating HS.

Go Now

MAKE A PLAN

TELL YOUR DERMATOLOGIST HOW YOU REALLY FEEL.

Be real about how you feel with your doctor. Use our Doctor Conversation Starter to help you have a better conversation about how hidradenitis suppurativa affects you.

Get Started

Tap to see IMPORTANT SAFETY INFORMATION AND APPROVED USES

IMPORTANT SAFETY INFORMATION

Do not use COSENTYX if you have had a severe allergic reaction to secukinumab or any of the other ingredients in COSENTYX. See the Medication Guide for a complete list of ingredients.

What is the most important information I should know about COSENTYX?

COSENTYX is a medicine that affects your immune system. COSENTYX may increase your risk of having serious side effects such as…

Do not use COSENTYX if you have had a severe allergic reaction to secukinumab or any of the other ingredients in COSENTYX. See the Medication Guide for a complete list of ingredients.

What is the most important information I should know about COSENTYX?

COSENTYX is a medicine that affects your immune system. COSENTYX may increase your risk of having serious side effects such as:

Infections

COSENTYX may lower the ability of your immune system to fight infections and may increase your risk of infections. Some people have died from these infections.

  • Your doctor should check you for tuberculosis (TB) before starting treatment with COSENTYX.

  • If your doctor feels that you are at risk for TB, you may be treated with medicine for TB before you begin treatment with COSENTYX and during treatment with COSENTYX.

  • Your doctor should watch you closely for signs and symptoms of TB during treatment with COSENTYX. Do not use COSENTYX if you have an active TB infection.

Before starting COSENTYX, tell your doctor if you:

  • are being treated for an infection

  • have an infection that does not go away or that keeps coming back

  • have TB or have been in close contact with someone with TB

  • think you have an infection or have symptoms of an infection such as: fevers, sweats, or chills; muscle aches; cough; shortness of breath; blood in your phlegm; weight loss; warm, red, or painful skin or sores on your body; diarrhea or stomach pain; burning when you urinate or urinate more often than normal

After starting COSENTYX, call your doctor right away if you have any signs of infection listed above. Do not use COSENTYX if you have any signs of infection unless you are instructed to by your doctor.

What are the possible side effects of COSENTYX?

COSENTYX may cause serious side effects, including: 

Serious allergic reactions

Serious allergic reactions can occur. Get emergency medical help right away if you get any of the following symptoms: feeling faint; swelling of your face, eyelids, lips, mouth, tongue, or throat; trouble breathing or throat tightness; chest tightness; skin rash or hives (red, itchy bumps).

If you have a severe allergic reaction, do not give another injection of COSENTYX.

Inflammatory bowel disease

New cases of inflammatory bowel disease or "flare-ups" can happen with COSENTYX, and can sometimes be serious. If you have inflammatory bowel disease (ulcerative colitis or Crohn's disease), tell your doctor if you have worsening disease symptoms during treatment with COSENTYX or develop new symptoms of stomach pain or diarrhea.

Severe skin reactions that look like eczema can happen during treatment with COSENTYX from days to months after your first dose and can sometimes lead to hospitalization. Your doctor may temporarily stop treatment with COSENTYX if you develop severe skin reactions. Tell your doctor if you have any of the following signs or symptoms: redness or rash; itching; small bumps or patches; your skin is dry or feels like leather; blisters on the hands or feet that ooze or become crusty or skin peeling.

The most common side effects of COSENTYX include: cold symptoms, diarrhea, and upper respiratory tract infections.

These are not all of the possible side effects of COSENTYX. Call your doctor for medical advice about side effects.

Before using COSENTYX, tell your doctor if you:

  • have any of the conditions or symptoms listed above for infections.

  • have inflammatory bowel disease (Crohn's disease or ulcerative colitis).

  • are allergic to latex. The needle cap on the COSENTYX Sensoready® pen, and 150 mg/mL and 75 mg/0.5 mL prefilled syringes contains latex.

  • have recently received or are scheduled to receive an immunization (vaccine). People who take COSENTYX should not receive live vaccines. Children should be brought up to date with all vaccines before starting COSENTYX.

  • have any other medical conditions and all the medicines you take, including prescription and over‑the‑counter medicines, vitamins, and herbal supplements. Keep a list of your medicines to show your healthcare provider and pharmacist when you get a new medicine.

  • are pregnant or plan to become pregnant. It is not known if COSENTYX can harm your unborn baby. You and your doctor should decide if you will use COSENTYX.

  • are breastfeeding or plan to breastfeed. It is not known if COSENTYX passes into your breast milk.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch ↗, or call 1-800-FDA-1088.

Please see full Prescribing Information, including Medication Guide.

10/23  308659

INDICATIONS

COSENTYX® (secukinumab) is a prescription medicine used to treat:

  • people 6 years of age and older with moderate to severe plaque psoriasis (PsO) that involves large areas or many areas of the body, and who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light alone or with systemic therapy)…

COSENTYX® (secukinumab) is a prescription medicine used to treat:

  • people 6 years of age and older with moderate to severe plaque psoriasis (PsO) that involves large areas or many areas of the body, and who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light alone or with systemic therapy)

  • people 2 years of age and older with active psoriatic arthritis (PsA)

  • adults with active ankylosing spondylitis (AS)

  • adults with active non-radiographic axial spondyloarthritis (nr-axSpA) and objective signs of inflammation 

  • people 4 years of age and older with active enthesitis-related arthritis (ERA)

  • adults with moderate to severe hidradenitis suppurativa (HS)

Click or scroll to see IMPORTANT SAFETY INFORMATION AND APPROVED USES
*Limitations apply. Valid only for those with private insurance. Program provides up to $16,000 annually for the cost of COSENTYX and up to $150 per infusion (up to $1,950 annually) for the cost of administration. Co-pay support for infusion administration cost not available in Rhode Island or Massachusetts. Offer not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice. See complete Terms & Conditions for details.